Introduction: A group of SARS-CoV-2 infected individuals present lingering symptoms, defined as long COVID (LC), that may last months or years …
Read moreLibrary
We have over 7,000 research abstracts in our library, as well as articles, news items, and press releases. You can search the library by topic, keywords, author, or date. You can also search categories and tags.
Abstract: With an estimated 65 million individuals suffering from Long COVID, validated therapeutic strategies as well as non-invasive biomarkers are …
Read moreBackground and aims: Myalgic encephalomyelitis (ME) is a complex, debilitating and heterogeneous disorder. It affects over 500,000 people in Canada …
Read moreAbstract: Background Long COVID (LC) is novel, debilitating and likely chronic. Yet, scant data exist about its disability burden to guide …
Read moreAbstract: Background Cardiac risk rises during acute SARS-CoV-2 infection and in long COVID syndrome in humans, but the mechanisms behind COVID-19-linked …
Read moreAbstract: The use of CD169 as a marker of viral infection has been widely discussed in the context of COVID-19, …
Read moreAbstract: This prospective cohort study aimed to identify characteristics of long COVID and any potential mitigating effects of COVID-19 vaccinations …
Read moreHighlights: Growing evidence suggests that persistent microvascular inflammation, clumping/clotting of blood cells and thrombotic complications may be key causes of Long …
Read moreAbstract: Oral nirmatrelvir/ritonavir is approved as treatment for acute COVID-19, but the effect of treatment during acute infection on risk …
Read moreAbstract: Background: While stroke and lower extremity venous thromboemboli have been commonly reported following acute infection with severe acute respiratory syndrome …
Read more